Martingale Asset Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $533K | Sell |
10,903
-889
| -8% | -$43.4K | 0.01% | 608 |
|
|
2025
Q1 | $601K | Sell |
11,792
-3,246
| -22% | -$165K | 0.02% | 571 |
|
|
2024
Q4 | $679K | Sell |
15,038
-1,454
| -9% | -$65.6K | 0.02% | 553 |
|
|
2024
Q3 | $612K | Sell |
16,492
-3
| -0% | -$111 | 0.01% | 587 |
|
|
2024
Q2 | $504K | Sell |
16,495
-98
| -0.6% | -$3K | 0.01% | 593 |
|
|
2024
Q1 | $483K | Buy |
16,593
+500
| +3% | +$14.5K | 0.01% | 625 |
|
|
2023
Q4 | $444K | Sell |
16,093
-3,524
| -18% | -$97.1K | 0.01% | 634 |
|
|
2023
Q3 | $440K | Buy |
19,617
+3
| +0% | +$67 | 0.01% | 633 |
|
|
2023
Q2 | $798K | Buy |
19,614
+3
| +0% | +$122 | 0.02% | 506 |
|
|
2023
Q1 | $950K | Buy |
19,611
+6,893
| +54% | +$334K | 0.02% | 454 |
|
|
2022
Q4 | $485K | Buy |
+12,718
| New | +$485K | 0.01% | 619 |
|
|
2021
Q4 | – | Sell |
-8,117
| Closed | -$303K | – | 878 |
|
|
2021
Q3 | $303K | Buy |
+8,117
| New | +$303K | ﹤0.01% | 749 |
|
|
2021
Q1 | – | Sell |
-4,217
| Closed | -$258K | – | 898 |
|
|
2020
Q4 | $258K | Buy |
+4,217
| New | +$258K | ﹤0.01% | 776 |
|